Univercells
VerifiedDesigning biological solutions for healthcare providers making biologics available to everyone.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$385m (Public information from May 2023)
Company register number 0502.742.288
Charleroi Hainaut Province (HQ)
Deals in current and previous year:
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 9 % | (1 %) | 27 % | 28 % | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (148 %) | (334 %) | (508 %) | (710 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (199 %) | (390 %) | (678 %) | (949 %) | - | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor investor investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor investor | $0.0 Valuation: $0.0 -51.6x EV/LTM EBITDA | round | |
* | N/A | €15.0m Valuation: €350m -41.1x EV/LTM EBITDA | Series D |
| Total Funding | 000k | ||
Related Content
Recent News about Univercells
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Univercells
Edit
ACQUISITION by Univercells Jan 2022